Immunotherapy

The immunotherapy pembrolizumab may help some people with incurable cervical cancer live longer. It’s now an approved treatment for them in England and Scotland.

We’re helping treble funding for paediatric Experimental Cancer Medicine Centres, paving the way to more effective and less toxic treatments for children and young people.

Cancer vaccine development has had many challenges. But with recent breakthroughs and new partnerships, could we be closer than ever?

Researchers have found a way to deliver cancer-killing viruses to tumours by hiding them inside immune cells.

The “potentially life-saving” immunotherapy drug pembrolizumab is now recommended for some people with early triple negative breast cancer in England and Wales.

Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs

Forty years ago, hints of a new component of the immune system caused a stir. Here, we chart the story of gamma delta T cells from discovery to clinical trials…

Hope for patients with early-stage lung cancer as new treatment approved for use on NHS England.

3 new cancer treatments have now been approved by the Scottish Medicines Consortium (SMC) for use on the NHS in Scotland, including 2 breast cancer treatments and 1 for lung cancer.

A new treatment for some people with a type of non small cell lung cancer (NSCLC) will now be routinely available on the NHS in England, following its approval by the National Institute of Health and Care Excellence (NICE).